Uveal melanoma, version 1.2019 featured updates to the NCCN guidelines

P. Kumar Rao, Christopher Barker, Daniel G. Coit, Richard W. Joseph, Miguel Materin, Ramesh Rengan, Jeffrey Sosman, John A. Thompson, Mark R. Albertini, Genevieve Boland, William E. Carson, Carlo Contreras, Gregory A. Daniels, Dominick DiMaio, Alison Durham, Ryan C. Fields, Martin D. Fleming, Anjela Galan, Brian Gastman, Kenneth GrossmanValerie Guild, Douglas Johnson, Giorgos Karakousis, Julie R. Lange, Kim Margolin, Sameer Nath, Anthony J. Olszanski, Patrick A. Ott, Merrick I. Ross, April K. Salama, Joseph Skitzki, Susan M. Swetter, Evan Wuthrick, Nicole R. McMillian, Anita Engh

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

The NCCN Guidelines for Uveal Melanoma include recommendations for staging, treatment, and follow-up of patients diagnosed with uveal melanoma of the choroid or ciliary body. In addition, because distinguishing between uveal melanoma and benign uveal nevi is in some cases difficult, these guidelines also contain recommendations for workup of patients with suspicious pigmented uveal lesions, to clarify the tests needed to distinguish between those who should have further workup and treatment for uveal melanoma versus those with uncertain diagnosis and low risk who should to be followed and later reevaluated. These NCCN Guidelines Insights describe recommendations for treatment of newly diagnosed nonmetastatic uveal melanoma in patients who have already undergone a complete workup.

Original languageEnglish (US)
Pages (from-to)121-131
Number of pages11
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume18
Issue number2
DOIs
StatePublished - 2020

ASJC Scopus subject areas

  • Oncology

Fingerprint

Dive into the research topics of 'Uveal melanoma, version 1.2019 featured updates to the NCCN guidelines'. Together they form a unique fingerprint.

Cite this